NIOX Group PLC
NIOX
Company Profile
Business description
NIOX Group PLC is a medical device company that develops a range of therapies for asthma, chronic obstructive pulmonary disease, and allergy. The company has a single operating segment: NIOX. The NIOX segment relates to the portfolio of products used to improve asthma diagnosis and management by measuring fractional exhaled nitric oxide (FeNO). Geographically, it derives a majority of its revenue from the Asia Pacific and also has a presence in the European Union, the United States, the United Kingdom, and the Rest of the world.
Contact
1 Robert Robinson Avenue
The Magdalen Centre
The Oxford Science Park
OxfordOX4 4GA
GBRT: +44 3303309356
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2025
Employees
84
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,646.30 | 21.40 | 0.25% |
CAC 40 | 7,788.10 | 38.69 | -0.49% |
DAX 40 | 24,038.19 | 188.30 | -0.78% |
Dow JONES (US) | 42,098.70 | 244.95 | -0.58% |
FTSE 100 | 8,726.01 | 52.04 | -0.59% |
HKSE | 23,477.79 | 219.48 | 0.94% |
NASDAQ | 19,100.94 | 98.22 | -0.51% |
Nikkei 225 | 38,352.14 | 629.74 | 1.67% |
NZX 50 Index | 12,281.31 | 80.95 | -0.65% |
S&P 500 | 5,888.55 | 32.99 | -0.56% |
S&P/ASX 200 | 8,419.30 | 22.40 | 0.27% |
SSE Composite Index | 3,364.10 | 24.17 | 0.72% |